Trends in the incidence of the Epstein-Barr virus-associated malignancies extranodal NK/T-cell lymphoma and nasopharyngeal carcinoma in Taiwan

被引:0
|
作者
Yeh, Shyh-An [1 ,2 ,3 ,4 ]
Chiu, Liang-Chun [5 ]
Lin, Hsin-Chieh [6 ,7 ]
Li, Hung-Ju [8 ]
Lin, Sheng-Fung [8 ]
Su, Yu-Chieh [8 ,9 ,10 ]
机构
[1] Natl Kaohsiung Univ Sci & Technol, Med Phys & Informat Lab Elect Engn, Kaohsiung, Taiwan
[2] Natl Kaohsiung Univ Sci & Technol, Dept Elect Engn, Kaohsiung, Taiwan
[3] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan
[4] I Shou Univ, E DA Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan
[5] I Shou Univ, E Da Dachang Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan
[6] I Shou Univ, E Da Canc Hosp, Dept Chinese Med, Kaohsiung, Taiwan
[7] I Shou Univ, Sch Chinese Med Post Baccalaureate, Coll Med, Kaohsiung, Taiwan
[8] I Shou Univ, E Da Hosp, Div Hematol Oncol, Dept Internal Med, Kaohsiung, Taiwan
[9] I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan
[10] I Shou Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan
来源
PLOS ONE | 2024年 / 19卷 / 12期
关键词
EPIDEMIOLOGY; NASAL; JAPAN; RISK;
D O I
10.1371/journal.pone.0315380
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nasopharyngeal carcinoma (NPC) and extranodal NK/T-cell lymphoma (ENKTL) are associated with the Epstein-Barr virus (EBV). The current study aimed to evaluate the trends in the incidence of ENKTL and NPC in Taiwan within the last 15-30 years. To assess the incidence of ENKTL from 2008 to 2021 and NPC from 1995 to 2021, an epidemiological study was performed using population-based registry data from the Taiwan Cancer Registry. The secular trends in the annual incidence rates were expressed as average annual percent change (AAPC). During the study period, 872 new ENKTL diagnoses and 39412 new NPC diagnoses were reported. The annual age-adjusted incidence rates of ENKTL and NPC decreased significantly, with an AAPC of -2.47 (p = 0.014) and -1.16 (p < 0.001), respectively. The incidence rates of NPC from 1995 to 2021 in the 20-44-, 45-64-, and >= 65-year-old age groups decreased from 5.23 to 4.42 per 100,000 person-years (AAPC = -0.45, p = 0.011), from 15.28 to 11.36 per 100,000 person-years (AAPC = -1.21, p < 0.001), and from 10.48 to 7.24 per 100,000 person-years (AAPC = -1.91, p < 0.001), respectively. The age-specific incidence rates of ENKTL in the 45-64-year-old age group significantly decreased from 0.46 to 0.32 per 100,000 person-years during 2008-2021 (AAPC = -3.37, p = 0.008). The incidence of ENKTL between 2008 and 2021 in the 20-44- and >= 65-year-old age groups also decreased from 0.16 to 0.11 per 100,000 person-years and from 0.87 to 0.79 per 100,000 person-years, respectively. Interestingly, the EBV seroprevalence in Taiwan remained stable from 1984 to 2007. Nonetheless, there was a downward trend in the EBV seroprevalence in early childhood, with a decrease of approximately 20% in children aged 4 years and nearly 50% in children aged <2 years. Based on these findings, the downward trend in the incidence of NPC/ENKTL could be affected by the decline in early EBV infection rates. Considering that the EBV seroprevalence remained stable but the incidence rate of early EBV infection decreased during the same period, delayed EBV infection or factors other than EBV might play an important role in the downward trend in the incidence of NPC/ENKTL in Taiwan. Nevertheless, further investigations should be performed to assess these results.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Claudin expression profiles in Epstein-Barr virus-associated nasopharyngeal carcinoma
    Kojima, Fumiyoshi
    Ishida, Mitsuaki
    Takikita-Suzuki, Mikiko
    Hotta, Machiko
    Katsura, Kanade
    Nagata, Akihiro
    Enoki, Yasuyuki
    Kato, Gen-Ichi
    Okabe, Hidetoshi
    ONCOLOGY REPORTS, 2010, 23 (04) : 927 - 931
  • [32] Identification of genes involved in Epstein-Barr virus-associated nasopharyngeal carcinoma
    Wang, Junguo
    Mei, Fang
    Gao, Xia
    Wang, Shoulin
    ONCOLOGY LETTERS, 2016, 12 (04) : 2375 - 2380
  • [33] EPSTEIN-BARR VIRUS-ASSOCIATED ANTIBODIES AND SERUM BIOCHEMISTRY IN NASOPHARYNGEAL CARCINOMA
    LYNN, TC
    HSIEH, RP
    HUANG, SC
    CHUANG, CY
    HSIEH, T
    TU, SM
    LARYNGOSCOPE, 1984, 94 (11): : 1485 - 1488
  • [34] Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: Clinicopathologic, serologic, and molecular analysis
    Mitarnun, W
    Suwiwat, S
    Pradutkanchana, J
    Saechan, V
    Ishida, T
    Takao, S
    Mori, A
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (01) : 31 - 38
  • [35] The contribution of Epstein-Barr virus to the impaired T-cell responses in nasopharyngeal carcinoma
    Lee, Hui Min
    Haigh, Tracey
    Tsao, George S. W.
    Murray, Paul G.
    Taylor, Graham
    Paterson, Ian C.
    Yap, Lee Fah
    CANCER RESEARCH, 2018, 78 (13)
  • [36] EPSTEIN-BARR VIRUS SPECIFIC T-CELL RESPONSE IN NASOPHARYNGEAL CARCINOMA PATIENTS
    MOSS, DJ
    CHAN, SH
    BURROWS, SR
    CHEW, TS
    KANE, RG
    STAPLES, JA
    KUNARATNAM, N
    INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (03) : 301 - 305
  • [37] Extranodal NK/T-cell Lymphoma, Nasal Type, Possibly Arising from Chronic Epstein-Barr Virus Infection
    Seishima, Mariko
    Yuge, Masaaki
    Kosugi, Hiroshi
    Nagasaka, Tetsuro
    ACTA DERMATO-VENEREOLOGICA, 2010, 90 (01) : 102 - 103
  • [38] Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan
    Wang, Ren-Ching
    Chang, Sheng-Tsung
    Hsieh, Yen-Chuan
    Huang, Wan-Ting
    Hsu, Jeng-Dong
    Tseng, Chih-En
    Wang, Ming-Chung
    Hwang, Wei-Shou
    Wang, John
    Chuang, Shih-Sung
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (05): : 2430 - 2437
  • [39] Treatment of Epstein-Barr virus-associated malignancies with specific T cells
    Gottschalk, S
    Heslop, HE
    Rooney, CM
    ADVANCES IN CANCER RESEARCH, VOL 84, 2002, 84 : 175 - 201
  • [40] Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
    Fujiwara, Shigeyoshi
    Kimura, Hiroshi
    FRONTIERS IN PEDIATRICS, 2019, 7